Previous studies have shown that patients evaluation of lipodystrophy and measurements of adherence is accurate. The cross sectional GRAAL study aims at analysing the impact of lipodystrophy on drug adherence, measured by self-assessment questionnaires.
Does lipodystrophy affect adherence? The cross-sectional GRAAL study / Guaraldi, Giovanni; Orlando, G.; Covezzi, R.; Orlandi, E.; Sterrantino, G. K.; Sbaragli, S.; Borderi, M.; Talò, S.; Grosso, C.; Erba, C.; Coronada, O.; Della Loggia, P.; Murri, R.; Antinori, A.; Esposito, Roberto. - STAMPA. - not applicable:(2001), pp. 28 (N:P-57)-28. (Intervento presentato al convegno 2nd European workshop on lipodystrophy tenutosi a Cannes, France nel 19-21/4/2001).
Does lipodystrophy affect adherence? The cross-sectional GRAAL study
GUARALDI, Giovanni;ESPOSITO, Roberto
2001
Abstract
Previous studies have shown that patients evaluation of lipodystrophy and measurements of adherence is accurate. The cross sectional GRAAL study aims at analysing the impact of lipodystrophy on drug adherence, measured by self-assessment questionnaires.
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
